- Investing Ideas
- Bangladeshi Pharmaceuticals & Biotech Undervalued based on future growth
Bangladeshi Pharmaceuticals & Biotech Undervalued based on future growth
Results
3
0 new
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
3 companies
Square Pharmaceuticals
Market Cap: ৳190.1b
Manufactures, markets, and distributes pharmaceutical products in Bangladesh and internationally.
SQURPHARMA
৳214.50
7D
-5.0%
1Y
-1.4%
Beximco Pharmaceuticals
Market Cap: ৳51.2b
Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh.
BXPHARMA
৳114.80
7D
-12.8%
1Y
46.6%
Renata
Market Cap: ৳49.2b
Manufactures, markets, and distributes pharmaceuticals, animal health medicines, oncology-based, agro-based, poultry, and consumer products in Bangladesh.
RENATA
৳429.20
7D
-5.5%
1Y
-14.5%